EFNS guidelines on the molecular diagnosis of mitochondrial disorders - PubMed (original) (raw)
Practice Guideline
. 2009 Dec;16(12):1255-64.
doi: 10.1111/j.1468-1331.2009.02811.x.
H F Harbo, J Baets, C Van Broeckhoven, S Di Donato, B Fontaine, P De Jonghe, A Lossos, T Lynch, C Mariotti, L Schöls, A Spinazzola, Z Szolnoki, S J Tabrizi, C M E Tallaksen, M Zeviani, J-M Burgunder, T Gasser; European Federation of Neurological Sciences
Affiliations
- PMID: 19950421
- DOI: 10.1111/j.1468-1331.2009.02811.x
Practice Guideline
EFNS guidelines on the molecular diagnosis of mitochondrial disorders
J Finsterer et al. Eur J Neurol. 2009 Dec.
Abstract
Objectives: These European Federation of Neurological Sciences (EFNS) guidelines are designed to provide practical help for the general neurologist to make appropriate use of molecular genetics for diagnosing mitochondrial disorders (MIDs), which gain increasing attention and are more frequently diagnosed due to improved diagnostic tools.
Background: Since the publication of the first EFNS guidelines on the molecular diagnosis of inherited neurological diseases in 2001, rapid progress has been made in this field, necessitating the creation of an updated version.
Search strategy: To collect data about the molecular diagnosis of MIDs search for literature in various electronic databases, such as Cochrane library, MEDLINE, OMIM, GENETEST or Embase, were carried out and original papers, meta-analyses, review papers, and guideline recommendations were reviewed.
Results: The guidelines summarise the possibilities and limitations of molecular genetic diagnosis of MIDs and provide practical recommendations and diagnostic criteria in accordance with the EFNS Scientific Committee to guide the molecular diagnostic work-up of MIDs.
Recommendations: The proposed guidelines suggest an approach to the molecular diagnosis of MIDs in a manner accessible to general neurologists.
Similar articles
- EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington's disease, Parkinson's disease and dystonias.
Harbo HF, Finsterer J, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, De Jonghe P, Lossos A, Lynch T, Mariotti C, Schöls L, Spinazzola A, Szolnoki Z, Tabrizi SJ, Tallaksen C, Zeviani M, Burgunder JM, Gasser T; EFNS. Harbo HF, et al. Eur J Neurol. 2009 Jul;16(7):777-85. doi: 10.1111/j.1468-1331.2009.02646.x. Epub 2009 May 12. Eur J Neurol. 2009. PMID: 19469830 - EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias.
Burgunder JM, Finsterer J, Szolnoki Z, Fontaine B, Baets J, Van Broeckhoven C, Di Donato S, De Jonghe P, Lynch T, Mariotti C, Schöls L, Spinazzola A, Tabrizi SJ, Tallaksen C, Zeviani M, Harbo HF, Gasser T; EFNS. Burgunder JM, et al. Eur J Neurol. 2010 May;17(5):641-8. doi: 10.1111/j.1468-1331.2010.02985.x. Epub 2010 Mar 9. Eur J Neurol. 2010. PMID: 20298421 - EFNS guidelines for the molecular diagnosis of neurogenetic disorders: motoneuron, peripheral nerve and muscle disorders.
Burgunder JM, Schöls L, Baets J, Andersen P, Gasser T, Szolnoki Z, Fontaine B, Van Broeckhoven C, Di Donato S, De Jonghe P, Lynch T, Mariotti C, Spinazzola A, Tabrizi SJ, Tallaksen C, Zeviani M, Harbo HF, Finsterer J. Burgunder JM, et al. Eur J Neurol. 2011 Feb;18(2):207-217. doi: 10.1111/j.1468-1331.2010.03069.x. Eur J Neurol. 2011. PMID: 20500522 - Cardiac manifestations of primary mitochondrial disorders.
Finsterer J, Kothari S. Finsterer J, et al. Int J Cardiol. 2014 Dec 20;177(3):754-63. doi: 10.1016/j.ijcard.2014.11.014. Epub 2014 Nov 5. Int J Cardiol. 2014. PMID: 25465824 Review. - Inherited mitochondrial disorders.
Finsterer J. Finsterer J. Adv Exp Med Biol. 2012;942:187-213. doi: 10.1007/978-94-007-2869-1_8. Adv Exp Med Biol. 2012. PMID: 22399423 Review.
Cited by
- Three-parent babies: Mitochondrial replacement therapies.
Farnezi HCM, Goulart ACX, Santos AD, Ramos MG, Penna MLF. Farnezi HCM, et al. JBRA Assist Reprod. 2020 May 1;24(2):189-196. doi: 10.5935/1518-0557.20190086. JBRA Assist Reprod. 2020. PMID: 32073245 Free PMC article. Review. - Cognitive Profile of Patients With Mitochondrial Chronic Progressive External Ophthalmoplegia.
Zhang G, Hou Y, Wang Z, Ye Z. Zhang G, et al. Front Neurol. 2020 Jan 29;11:36. doi: 10.3389/fneur.2020.00036. eCollection 2020. Front Neurol. 2020. PMID: 32063883 Free PMC article. - Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells.
Pek NMQ, Phua QH, Ho BX, Pang JKS, Hor JH, An O, Yang HH, Yu Y, Fan Y, Ng SY, Soh BS. Pek NMQ, et al. Cell Death Dis. 2019 Oct 22;10(11):802. doi: 10.1038/s41419-019-2036-9. Cell Death Dis. 2019. PMID: 31641105 Free PMC article. - Whole Exome Sequencing Is the Preferred Strategy to Identify the Genetic Defect in Patients With a Probable or Possible Mitochondrial Cause.
Theunissen TEJ, Nguyen M, Kamps R, Hendrickx AT, Sallevelt SCEH, Gottschalk RWH, Calis CM, Stassen APM, de Koning B, Mulder-Den Hartog ENM, Schoonderwoerd K, Fuchs SA, Hilhorst-Hofstee Y, de Visser M, Vanoevelen J, Szklarczyk R, Gerards M, de Coo IFM, Hellebrekers DMEI, Smeets HJM. Theunissen TEJ, et al. Front Genet. 2018 Oct 12;9:400. doi: 10.3389/fgene.2018.00400. eCollection 2018. Front Genet. 2018. PMID: 30369941 Free PMC article. - Mitochondrial mutations in 12S rRNA and 16S rRNA presenting as chronic progressive external ophthalmoplegia (CPEO) plus: A case report.
Lv ZY, Xu XM, Cao XF, Wang Q, Sun DF, Tian WJ, Yang Y, Wang YZ, Hao YL. Lv ZY, et al. Medicine (Baltimore). 2017 Dec;96(48):e8869. doi: 10.1097/MD.0000000000008869. Medicine (Baltimore). 2017. PMID: 29310369 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical